Genovis AB today announces the commercial launch of AlligBAITOR™, a novel immunoglobulin-binding protein that expands the company’s offering in advanced protein analysis. The product enables capture of all major antibody isotypes and uniquely facilitates the release of antigens from antibody-antigen complexes under native conditions. Together with the high-performance enzymes added through the recent acquisition of […]
Accelerating Entry into the Middle East Energy Transition Market HORIBA, Ltd. (President: Masayuki Adachi; hereinafter “HORIBA”) announced on February 13, 2026, the establishment of HORIBA Middle East Limited in Abu Dhabi. The new company marks HORIBA’s first presence in the Middle East and will be located in Masdar City, a pioneering sustainable urban community and […]
Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion). Darmstadt, Germany Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS […]
IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time. Waters Biosciences’ technologies, including BD FACSDiscover™ and BD Rhapsody™ Instruments, will be used with IMU’s AI analytics in research to deliver deeper, population-level disease insights. Partnership supports IMU’s expansion of […]
Männedorf, Switzerland — Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to […]
HAYWARD, Calif. — Applied Biomics, Inc., a leading provider of Host Cell Protein (HCP) products and HCP services, today announced the new Antigen Affinity Purified HCP Antibodies. The new product line expands the company’s portfolio of high-performance HCP antibody solutions for use in biopharmaceutical process development and quality control. Unlike conventional antigen affinity-purified antibodies, which often recognize only a […]
Eli Lilly and Company’s Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina’s Board SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026. Dr. Skovronsky brings extensive experience in drug discovery, clinical development and […]
Proven leader to drive sharper execution and faster breakthroughs across research, diagnostics, and advanced therapeutics Integrated DNA Technologies (IDT), a global leader in genomics, and Aldevron, a global leader in the production of DNA, RNA and protein, today announced that Jennifer Meade has been appointed president of IDT and Aldevron. As head of Aldevron since 2023, […]
The PPSQ-51A/53A Protein Sequencer Edman Degradation Unit (Right) and Liquid Chromatograph (Left) On June 19, Shimadzu Corporation released the PPSQ-51A/53A SPD-40 model protein sequencers. These instruments can be used to analyze the amino acid sequences in proteins, such as for quality control of antibody drugs or peptide drugs and has ” suitable for routine operations ” […]
Boster Biological Technology, a life science reagent manufacturer based in Pleasanton, California, has broadened availability of its validated CD68 antibody marker, a rabbit monoclonal optimized for IHC performance in human FFPE specimens. Pleasanton, California, United States — Getting macrophage staining right in FFPE tissue has been a pain point for immunohistochemistry labs for years. Antigen […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
